From 16 to 19 May 2023, the specific program of P+F Products + Features GmbH in the forthcoming Euro PCR 2023 will be held at the Palais des Congrès in Paris.
Nontreated severe symptomatic tricuspid valve regurgitation is associated with significant morbidity and mortality. When a surgical correction is not feasible due to high operative risk, transcatheter treatment of the tricuspid valve has been suggested as an interesting valuable option.
Prof. Gaspardone spoke on channel LA7 to talk about the innovative Noblestitch device
The coronary stent, invented by Julio Palmaz in 1987, was defined by the prestigious IP Worldwide Magazine as one of the ten inventions of the 20th century that contributed to changing the world.
The NOBLESTICH EL system produced by the Nobles Medical Technology II USA, used by the Umberto I of Rome.
Eliminate the insufficiency of the mitral valve with the Carillon system.
